Drug Shortage Report for THYROGEN

Last updated on 2023-01-28 History
Report ID 172865
Drug Identification Number 02246016
Brand name THYROGEN
Common or Proper name THYROGEN
Company Name SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) THYROTROPIN ALFA
Strength(s) 0.9MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 2
ATC code V04CJ
ATC description OTHER DIAGNOSTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-10-24
Estimated end date 2023-02-17
Actual end date 2023-01-27
Shortage status Resolved
Updated date 2023-01-28
Company comments Transition between distribution centers. Inventory is available at wholesaler level and orders are being carefully managed to avoid shortage at patient level.
Health Canada comments
Tier 3 Status No
Company contact information Customer service contact info: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-01-28 English Compare
v6 2023-01-27 French Compare
v5 2023-01-27 English Compare
v4 2023-01-25 French Compare
v3 2023-01-25 English Compare
v2 2022-10-28 French Compare
v1 2022-10-28 English Compare

Showing 1 to 7 of 7